Table 1.

Descriptive statistics within treatment group for baseline values and 72-wk change in lipoprotein particle number and size

Treatment	Pioglitazone		Glimepiride
	Baseline	72-wk change	Baseline	72-wk change
Particle number (nmol/liter)
VLDL	72.4 ± 46.0	1.4 ± 45.6	72.1 ± 52.4	−5.2 ± 37.9
LDL	1472.8 ± 404.3	−193.0 ± 470.1a	1412.6 ± 393.9	−111.1 ± 349.2a
HDL	31.9 ± 7.1	−0.3 ± 5.8	31.5 ± 5.9	−0.9 ± 5.3
Particle size (nm)
VLDL	52.6 ± 9.4	−5.8 ± 9.9a	53.0 ± 10.7	−0.8 ± 10.0
LDL	20.5 ± 0.8	0.6 ± 0.7a	20.5 ± 0.7	0.2 ± 0.6b
HDL	8.6 ± 0.4	0.2 ± 0.3a	8.6 ± 0.3	−0.02 ± 0.29

Values are shown as mean ± sd. Tests for change at 72 wk were based on log₁₀ values for each variable.

^aP < 0.0001 for change within treatment group at 72 wk.

^bP < 0.001 for change within treatment group at 72 wk.